CALR and ovarian carcinoma: Yet another report showed that free oxaliplatin or phase-transition nanoparticles loaded with oxaliplatin caused translocation of CRT to the surface of ID8 mouse ovarian surface epithelial cell line, which is used as a syngeneic mouse model for human ovarian cancer.